{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:49:46Z","timestamp":1779342586741,"version":"3.51.4"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10,29]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>The antiphospholipid syndrome is a disorder characterized by recurrent thrombosis and the presence of antibodies specific to phospholipids. However, the diagnosis of this syndrome is hampered by the lack of a specific laboratory test. In this study an ELISA for the measurement of antibodies to solid-phase \u03b22-glycoprotein I (\u03b22-GPI) was established and compared with anticardiolipin antibodies for diagnosis of antiphospholipid syndrome. Significantly elevated levels of antibodies to \u03b22-GPI were found in all patients with definite antiphospholipid syndrome (median\u2003\u2003=\u2003\u200391 AU). Marginally elevated levels of antibodies to \u03b22-GPI were observed in 5% of patients with systemic lupus erythematosus (SLE; median\u2003\u2003=\u2003\u20034 AU), 1% with stroke (median\u2003\u2003=\u2003\u20033 AU), 13% with infectious mononucleosis (median\u2003\u2003=\u2003\u20033 AU), 10% with HIV infection (median\u2003\u2003=\u2003\u20033 AU) and 8% with VDRL false-positive serology for syphilis (median\u2003\u2003=\u2003\u20034 AU), but not in patients with rheumatoid factor, syphilis or carotid artery stenosis. In contrast, significantly raised levels of anticardiolipin antibodies were observed in 100% of patients with definite antiphospholipid syndrome, 30% with SLE, 88% with HIV infection, 94% with syphilis, 62% with infectious mononucleosis, 9% with rheumatoid factor-positive sera, 74% VDRL false-positive serology for syphilis, 47% with stroke and 0% with carotid artery stenosis. This solid-phase assay for antibodies to \u03b22-GPI is highly specific for the antiphospholipid syndrome and represents an advance in the laboratory diagnosis of this disorder.<\/jats:p>","DOI":"10.1046\/j.1365-2249.1997.4601357.x","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T16:04:22Z","timestamp":1068134662000},"page":"304-309","source":"Crossref","is-referenced-by-count":74,"title":["Antibodies to \u03b22-glycoprotein I\u2014a specific marker for the antiphospholipid syndrome"],"prefix":"10.1093","volume":"109","author":[{"given":"J","family":"GUERIN","sequence":"first","affiliation":[{"name":"Department of Immunology, St James' Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"FEIGHERY","sequence":"additional","affiliation":[{"name":"Department of Immunology, St James' Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R B","family":"SIM","sequence":"additional","affiliation":[{"name":"MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"JACKSON","sequence":"additional","affiliation":[{"name":"Department of Immunology, St James' Hospital and The Dublin Institute of Technology, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2003,10,29]]},"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.1997.4601357.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.1997.4601357.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/109\/2\/304\/42205357\/j.1365-2249.1997.4601357.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/109\/2\/304\/42205357\/j.1365-2249.1997.4601357.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:42:18Z","timestamp":1676374938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/109\/2\/304\/6483399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2003,10,29]]},"published-print":{"date-parts":[[2003,10,29]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.1997.4601357.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,8]]},"published":{"date-parts":[[1997,8]]}}}